NO20072187L - Preventivt eller terapeutisk middel for glaucom - Google Patents

Preventivt eller terapeutisk middel for glaucom

Info

Publication number
NO20072187L
NO20072187L NO20072187A NO20072187A NO20072187L NO 20072187 L NO20072187 L NO 20072187L NO 20072187 A NO20072187 A NO 20072187A NO 20072187 A NO20072187 A NO 20072187A NO 20072187 L NO20072187 L NO 20072187L
Authority
NO
Norway
Prior art keywords
glaucoma
therapeutic agent
preventive
salt
preventing
Prior art date
Application number
NO20072187A
Other languages
English (en)
Norwegian (no)
Inventor
Shin Sugimoto
Ken Mizuno
Masatoshi Takahashi
Makoto Kanebako
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20072187L publication Critical patent/NO20072187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20072187A 2004-12-23 2007-04-27 Preventivt eller terapeutisk middel for glaucom NO20072187L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63811804P 2004-12-23 2004-12-23
PCT/JP2005/023570 WO2006068208A1 (ja) 2004-12-23 2005-12-22 緑内障予防又は治療剤

Publications (1)

Publication Number Publication Date
NO20072187L true NO20072187L (no) 2007-07-13

Family

ID=36601805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072187A NO20072187L (no) 2004-12-23 2007-04-27 Preventivt eller terapeutisk middel for glaucom

Country Status (24)

Country Link
EP (1) EP1818059B1 (de)
JP (1) JP4099201B2 (de)
KR (1) KR101286813B1 (de)
CN (1) CN101087613B (de)
AT (1) ATE415972T1 (de)
AU (1) AU2005320085B2 (de)
BR (1) BRPI0519007A2 (de)
CA (1) CA2585372A1 (de)
CY (1) CY1108651T1 (de)
DE (1) DE602005011476D1 (de)
DK (1) DK1818059T3 (de)
EA (1) EA011085B1 (de)
ES (1) ES2317338T3 (de)
HK (1) HK1113312A1 (de)
MX (1) MX2007007614A (de)
MY (1) MY138811A (de)
NO (1) NO20072187L (de)
NZ (1) NZ555137A (de)
PL (1) PL1818059T3 (de)
PT (1) PT1818059E (de)
SI (1) SI1818059T1 (de)
TW (1) TWI367098B (de)
WO (1) WO2006068208A1 (de)
ZA (1) ZA200704874B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4608546B2 (ja) * 2005-07-14 2011-01-12 シャープ株式会社 表示素子、及びこれを用いた電気機器
US20110184017A1 (en) 2008-07-25 2011-07-28 Asahi Kasei Pharma Corporation Stable aqueous solution composition containing sulfonamide compound
TW201235040A (en) * 2011-02-04 2012-09-01 Kowa Co Drug therapy for preventing or treating glaucoma
EA026904B1 (ru) * 2012-11-23 2017-05-31 Игорь Михайлович Юхт Способ количественного определения полигексаметиленбигуанидина (пгмб) гидрохлорида в составах для приготовления жидких лекарственных средств для лечения заболеваний глаз и носа (2 варианта)
US20160339018A1 (en) 2013-04-24 2016-11-24 Kyushu University, National University Corporation Therapeutic agent for ocular fundus disease
SG11201702299SA (en) * 2014-09-25 2017-04-27 Kowa Co Pharmaceutical product
JP6236166B2 (ja) * 2014-09-25 2017-11-22 興和株式会社 水性組成物
JP5951920B1 (ja) 2014-12-12 2016-07-13 興和株式会社 新規水性組成物
TWI699205B (zh) * 2014-12-12 2020-07-21 日商興和股份有限公司 用於預防或治療青光眼之藥物療法
KR20160108121A (ko) 2015-03-06 2016-09-19 코와 가부시키가이샤 수성 조성물
JP2018118905A (ja) * 2015-04-27 2018-08-02 恵 本庄 白内障術後合併症の予防治療剤
CN106310285A (zh) * 2015-06-15 2017-01-11 江苏吉贝尔药业股份有限公司 一种新的盐酸利舒地尔滴眼液及其制备方法
JP6886322B2 (ja) * 2016-03-25 2021-06-16 興和株式会社 眼科用組成物
CN107164328A (zh) * 2017-06-30 2017-09-15 太仓卡斯特姆新材料有限公司 一种高稳定性mcf‑7乳腺癌细胞的复苏方法
WO2019124488A1 (ja) 2017-12-21 2019-06-27 参天製薬株式会社 セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬
JP2020193174A (ja) * 2019-05-29 2020-12-03 興和株式会社 水性組成物
TW202237083A (zh) 2021-01-11 2022-10-01 美商英塞特公司 包含ｊａｋ路徑抑制劑及ｒｏｃｋ抑制劑之組合療法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401108D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
WO1997023222A1 (en) * 1995-12-21 1997-07-03 Alcon Laboratories, Inc. Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
JPH10310576A (ja) * 1997-03-10 1998-11-24 Hiroyoshi Hidaka イソキノリンスルフォンアミド誘導体及びこれを有効成分とする医薬
WO1999054306A1 (fr) * 1997-03-10 1999-10-28 Hiroyoshi Hidaka Derives isoquinolinesulfonamide et medicaments integrant ces derives comme principe actif
EP0977756A1 (de) * 1997-04-25 2000-02-09 Pfizer Limited Pyrazolopyrimidinone, die den typ 5 der cyclischen guanosin 3',5'-monophosphat phospodiesterase (cgmp pde5) hemmen, zur behandlung von sexuellen funktionsstörungen
FR2777189B1 (fr) 1998-04-09 2001-04-06 Chauvin Lab Sa Composition ophtalmique comprenant un beta-bloquant
JP4212149B2 (ja) * 1998-06-11 2009-01-21 株式会社デ・ウエスタン・セラピテクス研究所 医薬
CN1195547C (zh) 1998-08-17 2005-04-06 千寿制药株式会社 青光眼预防、治疗药
TR200101126T2 (tr) * 1998-10-22 2001-09-21 Neurosearch A/S İkameli fenil türevleri, hazırlanma ve kullanımları

Also Published As

Publication number Publication date
SI1818059T1 (sl) 2009-04-30
EA011085B1 (ru) 2008-12-30
ZA200704874B (en) 2008-08-27
EA200701134A1 (ru) 2007-10-26
JPWO2006068208A1 (ja) 2008-06-12
BRPI0519007A2 (pt) 2008-12-23
CY1108651T1 (el) 2014-04-09
TW200628160A (en) 2006-08-16
EP1818059A1 (de) 2007-08-15
MX2007007614A (es) 2007-08-15
TWI367098B (en) 2012-07-01
AU2005320085B2 (en) 2010-07-29
WO2006068208A1 (ja) 2006-06-29
PL1818059T3 (pl) 2009-05-29
ATE415972T1 (de) 2008-12-15
DE602005011476D1 (de) 2009-01-15
HK1113312A1 (en) 2008-10-03
MY138811A (en) 2009-07-31
AU2005320085A1 (en) 2006-06-29
JP4099201B2 (ja) 2008-06-11
CA2585372A1 (en) 2006-06-29
EP1818059B1 (de) 2008-12-03
CN101087613B (zh) 2010-08-18
ES2317338T3 (es) 2009-04-16
KR20070090897A (ko) 2007-09-06
PT1818059E (pt) 2008-12-31
CN101087613A (zh) 2007-12-12
DK1818059T3 (da) 2009-03-16
EP1818059A4 (de) 2007-12-26
KR101286813B1 (ko) 2013-07-17
NZ555137A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
NO20072187L (no) Preventivt eller terapeutisk middel for glaucom
WO2003092584A3 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
WO2007076360A8 (en) (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions
WO2006071548A3 (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
WO2006068829A9 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (lox) and lox-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
ATE529102T1 (de) Verbindung zur vorbeugung und behandlung von glaukoma
WO2007076367A3 (en) Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension / glaucoma
WO2005002520A3 (en) Ophthalmic compositions for treating ocular hypertension
HK1102913A1 (en) Statins for the treatment of ocular hypertension and glaucoma
WO2007098132A3 (en) Method and system for elasto-modulation of ocular tissue
WO2007126364A3 (en) Use of antisecretory factors for treating intraocular hypertension
WO2004069181A3 (en) Composition for the treatment of intraocular pressure
WO2003005941A3 (de) Insert zur behandlung des trockenen auges
EP1752158A4 (de) Pacap und sein derivat enthaltender korneaneuritogenese-promoter
WO2005027884A3 (en) Stabilized ocular solutions
WO2007127711A3 (en) Abnormal cannabidiols as agents for lowering intraocular pressure
EP1482922A4 (de) Mittel für die corneale oder intrastromale verabreichung zur behandlung oder prävention von erkrankungen des auges
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
TW200806284A (en) Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
WO2004087051A3 (en) Ophthalmic compositions for treating ocular hypertension
RU2007104148A (ru) Способ коррекции зрения после хирургических операций, выполненных на роговой оболочке глаза
UA37634A (uk) Спосіб хірургічного лікування відшарувань сітківки з гігантськими розривами

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application